Hama, Taketsugu
,
Nakanishi, Koichi http://orcid.org/0000-0001-8681-9129
Ishikura, Kenji
Ito, Shuichi
Nakamura, Hidefumi
Sako, Mayumi
Saito-Oba, Mari
Nozu, Kandai
Shima, Yuko
Iijima, Kazumoto
Yoshikawa, Norishige
Funding for this research was provided by:
The ministry of Health, Labor and Welfare, Japan (N/A)
Article History
Received: 21 June 2018
Accepted: 2 September 2018
First Online: 10 September 2018
Ethics approval and consent to participate
: This study is performed in accordance with the Declaration of Helsinki and is approved by the regional research ethics vetting boards (Wakayama Medical University). Before enrollment, patients’ guardians provided written informed consent, and informed assent was obtained from older children.
: Not applicable.
: KON received a lecture fee from Asahi Kasei Pharma Corp. KI received grants from Asahi Kasei Pharma Corp. and Pfizer Japan Inc., and a lecture fee from Asahi Kasei Pharma Corp. SI received grants from Asahi Kasei Pharma Corp. and Pfizer Japan Inc., and a lecture fee from Asahi Kasei Pharma Corp, Pfizer Japan Inc. and Shionogi & Co., Ltd. HN is a stockholder of Asahi Kasei Pharma Corp. KAN received a lecture fee from Asahi Kasei Pharma Corp. KI has received a grant from Takeda Pharmaceutical Co., Ltd., and lecture fees and/or consulting fees from Asahi Kasei Pharma Corp. and Takeda Pharmaceutical Co., Ltd. The other authors had no disclosure to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.